 |
   Tuesday, December 29, 2009
CVS Caremark Increases Investment in Generation HealthCompany strengthens its commitment to personalized medicineQD Vision Raises $10 Million in FinancingProvider of next generation display and lighting solutions to use new round of funding to support expansion and continued advancements of quantum dot-based LEDs.AVEO Pharmaceuticals Files Registration Statement for Initial Public OfferingBiopharmaceutical company focused on discovering and developing innovative cancer therapeutics files a Form S-1 with the U.S. Securities and Exchange Commission.Highland Capital Partners Announces $400 Million FundEighth fund will continue to fuel the firm’s focus on early through growth stage investments in exceptional healthcare, internet & digital media and technology companies.CVS Caremark and Generation Health Form Strategic Partnership to Offer Personalized MedicineCVS Caremark to improve individual health outcomes and reduce overall medical costs with the use of genetic testing. |
  At Highland Capital Partners, we have always been focused on one goal: to help great people build great companies. Since our inception in 1988, we have invested in over 200 seed, early and growth stage companies – 90 of which have gone public or been acquired to date. We emphasize a team-oriented approach in providing the right mix of strategic guidance, hands-on leadership and deep industry domain expertise in helping entrepreneurs and their teams to become market-leading organizations.
"There are certain things that you only know when you've been through them. As an early investor in Ocular, Highland's industry knowledge, experience and guidance were absolutely central to the success of our business."
Ed Kennedy Former CEO Ocular Networks |
 |
